Sixth Wave Innovations Inc. is pleased to provide an update on commercial deployment of the Affinity™ System for purification of cannabinoids. Green Envy Extracts will ramp up its production line in Michigan on or about December 15, 2021. Once production commences, SIXW will use the crude extract to complete performance testing on the Affinity System. Testing will occur three weeks earlier than initially planned. ...

Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) ("Sixth Wave", "SIXW" or the "Company") is pleased to provide an update on commercial deployment of the Affinity™ System (the "System") for purification of cannabinoids. Green Envy Extracts (customer) will ramp up its production line in Michigan on or about December 15, 2021. Once production commences, SIXW will use the crude extract to complete performance testing on the Affinity System. Testing will occur three weeks earlier than initially planned. SIXW has also completed the manufacture of Affinity™ nano-tech beads for use in the full-size production Affinity™ System scheduled for installation in Michigan. By year-end, SIXW will manufacture three additional bead orders that are slated to complete four production Affinity™ Systems.

"We are very pleased to continue our collaboration with Sixth Wave on the launch of the Affinity™ system," states Amato Spagnoletti, [Director] of Green Envy. "As a growing multi-state cannabis operator, we believe that our respective technological approaches will yield significant technical and commercial benefits as we commission the first Affinity system with Sixth Wave in Michigan. Per our signed MOU, we plan to purchase a minimum of 3 Affinity™ units for placement at additional locations in the coming months," he added.

Based on current operating procedures (SOP), the system will be capable of processing approximately 6kg of final high purity distillate every 10hrs of operation. The larger production unit will be capable of producing finished distillate of approximately 14kg/10hrs of operation or more than 30kg/day which surpasses the Company's 20kg/day goal. Sixth Wave will begin revenue generation with the initial system as soon as optimization trials are completed. A single production system will be capable of generating approximately CAD$2.25M annually based on a 300-day production schedule while netting the licensed producer cost savings/increased yield that should nearly double the Affinity™ related license costs.

Sixth Wave expects to see continued growth in the cannabis sector as State-by-State and potential Federal legalization efforts advance across the United States. The US House of Representatives House Judiciary Committee just passed The Marijuana Opportunity, Reinvestment, and Expungement or the MORE Act. Legalization will drive demand for cannabis processing capacity and support demand for the Affinity™ System.

The Company is in discussions with other early adopter candidates that have a significant presence within the industry in Canada and the United States. Further, SIXW is in joint venture negotiations with an organic cellular growth company that has chosen SIXW to lead its global cannabis product development as well as other high-value plants and roots used in food products, nutraceuticals, and medicines.

About Sixth Wave

Sixth Wave is a nanotechnology company with patented technologies that focus on extraction and detection of target substances at the molecular level using highly specialized Molecularly Imprinted Polymers (MIPs). The Company is in the process of a commercial rollout of its Affinity™ cannabinoid purification system, as well as IXOS®, a line of extraction polymers for the gold mining industry. The Company is also in the development stages of a rapid diagnostic test for viruses under the Accelerated MIPs (AMIPS™) label.

Sixth Wave can design, develop and commercialize MIP solutions across a broad spectrum of industries. The company is focused on nanotechnology architectures that are highly relevant for the detection and separation of viruses, biogenic amines, and other pathogens, for which the Company has products at various stages of development.

For more information about Sixth Wave, please visit our website at: www.sixthwave.com.

ON BEHALF OF THE BOARD OF DIRECTORS

"Jonathan Gluckman"
Jonathan Gluckman, Ph.D., President & CEO

For information, please contact the Company:
Phone: (801) 582-0559
E-mail: info@sixthwave.com

Cautionary Notes

This press release includes certain statements that may be deemed "forward-looking statements" including possible statements regarding the planned use of proceeds and performance of the IXOS®, Affinity™, and AMIPs™ technologies. All statements in this release, other than statements of historical facts, that address future events or developments that the Company expects, are forward-looking statements. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance, and actual events or developments may differ materially from those in forward-looking statements. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause the Company's actual performance and financial results in future periods to differ materially from any projections of future performance or results expressed or implied by such forward-looking statements. In particular, successful development and commercialization of the IXOS®, Affinity™, or AMIPs™ technologies are subject to the risk that they may not prove to be successful, the uncertainty of medical product development, the uncertainty of timing or availability of required regulatory approvals, lack of track record of developing products for certain applications and the need for additional capital to carry out product development activities. The value of any products ultimately developed could be negatively impacted if patents are not granted. The Company has not yet applied for regulatory approval for the use of this product from any regulatory agency.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/104142

News Provided by Newsfile via QuoteMedia

Sixth Wave and York University Co-Develop a Fluorometric Microfluidic AMIPs Device

Sixth Wave and York University Co-Develop a Fluorometric Microfluidic AMIPs Device

Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) ("Sixth Wave", "SIXW" or the "Company") is pleased to provide an update on the development of it's Accelerated Molecular Imprinted Polymers (AMIPs™) and ongoing collaboration with York University.

Sixth Wave has successfully integrated its AMIP technology into a multicomponent microfluidic device with fluorescent detection. The prototype device, created by Dr. Pouya Rezai's and Dr. Satinder Brar's groups at York University, coats a thin layer of AMIPs polymer onto fluorescent magnetic microparticles. As the ultra-thin AMIP polymer shell binds the target pathogen, a change in the fluorescent signal is detected by the device. The integration of the detectors with microfluidics devices and "lab-on-a-chip" designs allow screening for multiple pathogens with a single test/device.

Keep reading... Show less
Sixth Wave Achieves Electrical Detection with AMIPs Technology

Sixth Wave Achieves Electrical Detection with AMIPs Technology

Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) ("Sixth Wave", "SIXW" or the "Company") is pleased to provide an update on the Company's Accelerated Molecular Imprinted Polymers (AMIPs™) and collaboration with York University.

Sixth Wave has successfully demonstrated the ability to identify the capture of pathogens electrically with one of its AMIPs prototypes. The prototype device created at York University integrates SIXW's AMIPs technology into an electrical sensor by coating the electrical sensor with AMIP polymer. When the AMIPs selectively binds with the target pathogen, a corresponding electrical signal is detected by the device.

Keep reading... Show less
Sixth Wave Announces Addition of Honorable Grant Mitchell to the Board of Directors

Sixth Wave Announces Addition of Honorable Grant Mitchell to the Board of Directors

Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) ("Sixth Wave" or the "Company") is pleased to announce that the Honourable Grant Mitchell will be joining the Company's Board of Directors effective immediately. Mr. Mitchell has been a valuable component of the Company's Strategic Advisory Board and is a welcome addition to the Board. This move comes as the Company continues to expand the independence and expertise represented in the Board.

Mr. Mitchell was appointed to the Senate of Canada in 2005 on the advice of Prime Minister Paul Martin and represented Alberta until his retirement in 2020. Prior to his appointment to the Senate, Mr. Mitchell spent twelve years serving in the Alberta Legislature as MLA, including four years as Opposition Leader from 1994 to 1998. More recently Mr. Mitchell has been intimately involved with both business and legislative policy around the environment, social, and governance (ESG), carbon tax/credits, and other similar initiatives.

Keep reading... Show less
The Power Play by The Market Herald Releases New Interviews with Universal Ibogaine and Hank Payments on Their Latest News

The Power Play by The Market Herald Releases New Interviews with Universal Ibogaine and Hank Payments on Their Latest News

The Power Play by The Market Herald has announced the release of new interviews with Universal Ibogaine and Hank Payments discussing their latest press releases

The Power Play by The Market Herald provides investors with a quick snapshot of what they need to know about the company's latest press release through exclusive insights and interviews with company executives.

Keep reading... Show less
Universal Ibogaine Announces Chief Clinics Officer Dr Ian Rabb

Universal Ibogaine Announces Chief Clinics Officer Dr Ian Rabb

Universal Ibogaine Inc. (TSXV: IBO) ("Universal Ibogaine", "UI" or the "Company"), a life sciences company with a mission to research and deliver medicalized ibogaine-centered addiction care, is pleased to announce an expansion of its Executive Team and welcomes addiction treatment and clinic operations veteran Dr Ian Rabb as Chief Clinics Officer effective November 15, 2021 .

Keep reading... Show less
Billy Goat Brands

Billy Goat Brands



Overview

According to the Government of Canada, the blue economy is driven by sustainable ocean resources and accounts for about $31.65 billion annually in GDP. A significant factor in the blue economy is the preservation of aquatic life –– specifically, seafood. As a result, seafood alternatives are projected to reach a market size of US$1.6 billion in the next decade at a CAGR of 28 percent. With this in mind, companies with business models that support the blue economy and offer plant-based seafood alternatives will likely be of interest to investors seeking upside potential.

Billy Goat Brands (CSE:GOAT) ("GOAT" or the "Platform") is a venture capital platform focused on building a portfolio of high potential, expansion stage companies working in the blue economy. GOAT is dedicated to investing in and helping grow exciting and innovative companies with ESG values that address climate change, human wellness and the global demand for food security. The Platform's portfolio also offers investors early exposure to functional foods, food technologies and fermented food brands.

cdn.investingnews.com

According to the Government of Canada, the blue economy is driven by sustainable ocean resources and accounts for about $31.65 billion annually in GDP. A significant factor in the blue economy is the preservation of aquatic life –– specifically, seafood. As a result, seafood alternatives are projected to reach a market size of US$1.6 billion in the next decade at a CAGR of 28 percent. With this in mind, companies with business models that support the blue economy and offer plant-based seafood alternatives will likely be of interest to investors seeking upside potential.

Billy Goat Brands (CSE:GOAT) ("GOAT" or the "Platform") is a venture capital platform focused on building a portfolio of high potential, expansion stage companies working in the blue economy. GOAT is dedicated to investing in and helping grow exciting and innovative companies with ESG values that address climate change, human wellness and the global demand for food security. The Platform's portfolio also offers investors early exposure to functional foods, food technologies and fermented food brands.

cdn.investingnews.com

Each investee company currently in GOAT's portfolio is expected to grow rapidly over the next three years. Accordingly, the Platform plans to generate returns on its investments in several ways, including the public listing of its investee companies, mergers and acquisitions ("M&A") or other liquidity events.

Looking ahead, GOAT has identified more than 200 potential portfolio companies and has engaged in more than 40 advanced discussions to make investments into various ventures. It expects to conduct detailed due diligence on dozens of companies in order to arrive at an optimal portfolio of 5 to 10 holdings.

In October 2021, Billy Goat Brands signed a Letter of Intent to purchase an equity stake with Cascadia Seaweed, a vertically integrated company growing to become the largest provider of ultra-premium ocean cultivated seaweed in North America.

GOAT is led by an experienced management team that is well-versed in the nuances of the public markets, venture capital, M&A, strategy, corporate governance and operations. Its management team has executed over $5 billion of various debt and equity transactions. The team has also established highly successful channels, ideas and platforms for brands like Best Buy, Telus and Tourism BC.

Company Highlights

  • Billy Goat Brands (CSE:GOAT) is a venture capital platform focused on building a diversified portfolio of high potential, expansion-stage food and nutraceutical brands companies working in the blue economy with ESG values in the blue economy with ESG initiatives.
  • GOAT differentiates itself from a traditional investor as a partner that provides strategic assistance, network connections and support to its portfolio companies for faster scale and growth. All of Billy Goat Brand's portfolio companies have been more than satisfied with the assistance that Billy Goat Brands has provided to them.
  • GOAT's current portfolio consists of Sophie's Kitchen, KOLD, The Vegetarian Butcher and Evanesce Packaging. Sophie's Kitchen, the company's largest asset, focuses on delivering delicious and nutritious plant-based seafood alternatives that support a blue economy.
  • GOAT signed a Letter of Intent to invest in Cascadia Seaweed, a vertically integrated company growing to become the largest provider of ultra-premium ocean cultivated seaweed in North America
  • Each company that is currently in GOAT's portfolio is expected to produce a more than 50 percent CAGR in each of the next three years.
  • The company is led by an experienced management team that is well-versed in the nuances of the public markets, venture capital, M&A, strategy, corporate governance and operations.

Key Products


Keep reading... Show less

Top News

Related News